More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Notice of Allowance for Cynata US Patent

Nov 10, 2022 at 10:36 PM EST · Issued by Cynata Therapeutics Limited

Filed with ASX · Nov 10, 2022 at 10:36 PM EST · 2 pages · English

On 6ix: 6ix.com/news/notice-of-allowance-for-cynata-us-patent

Cynata Therapeutics Limited on 6ix

Story so far

  • Notice of Allowance for Australia & Canada Cymerus PatentsOct 17, 2022
  • Notice of Allowance for Cynata Chinese PatentFeb 28, 2022
  • Cynata Receives Notice of Allowance from US Patent OfficeAug 26, 2021

Earlier from Cynata Therapeutics

  • New Kidney Transplantation Clinical Trial for Cynata & LUMCNov 1, 2022
  • Notice of Allowance for Australia & Canada Cymerus PatentsOct 16, 2022
  • Successful Completion of Planned DSMB Review of DFU TrialOct 11, 2022
  • Grant Award to Fund Study of Cynata MSCs in Heart DiseaseSep 25, 2022
  • Pipeline Update Following Strategic Portfolio ReviewAug 11, 2022

Later from Cynata Therapeutics

  • Cynata Receives $1.65m R&D Tax Incentive RefundDec 4, 2022
  • Notice of Acceptance for Cynata Australian PatentJan 9, 2023
  • Cynata Receives IRB Approval for aGvHD Clinical TrialJan 29, 2023
  • Cynata Adds New Sites for DFU Clinical TrialMar 16, 2023
  • Cynata completes $5.0m Placement and launches SPPApr 5, 2023
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer